Developmental and Behavioral Health for the Pediatric Patient

Thursday, April 20, 2023, 7:30 AM - 5:30 PM, The Children's Hospital of Philadelphia, Philadelphia, PA


According to the CDC (2022), 1 out of 6 U.S. children have a developmental disorder or delay and 1 in 44 children will meet criteria for a diagnosis of Autism Spectrum Disorder. This conference will address some of the leading developmental and behavioral health concerns, including tackling some of the current controversies and including helpful resources. Each lecture will include evidence-based treatments, support management and resource suggestions, with the goal of providing attendees the most current best-practices and practical tips for caring for patients with developmental disabilities.

1. Participants will identify common developmental and behavioral health symptoms that can present in pediatric patients
2. Participants will identify common medical and mental health conditions that can occur with developmental or behavioral disorders and understand how they may impact the child’s function
3. Participants will identify resources that can be utilized in the office or shared with families to address developmental, behavioral or mental health concerns in children

The registration fee is $150 for physicians and $100 for nurses.

The Children's Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.

AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician AMA PRA Category 1 Credits™ Attendance (includes PA, RT, RDMS) (8.00 hours)

Mitigation of Relevant Financial Relationships

Children's Hospital of Philadelphia adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, April 20, 2023